Clinical Trial Update: Plaque Inflammation and Dysfunctional HDL in AIM-HIGH

View source ↗

Summary

AIM-HIGH trial update on plaque inflammation and dysfunctional HDL in patients with cardiovascular disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease
• Myocardial Infarction

Drugs mentioned

• Niaspan (niacin (nicotinic acid))

Snippet

Sponsor: University of Washington | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED